Highlights Fagron N.V.

Equities

Market Closed - Euronext Bruxelles Other stock markets 11:35:22 2024-05-08 EDT			After market 15:51:00
18.74 ^EUR	+1.52%		18.73	-0.05%

04-11	Transcript : Fagron NV, Q1 2024 Sales/ Trading Statement Call, Apr 11, 2024
04-11	Fagron Reports Revenue Results for the First Quarter Ended 31 March 2024	CI

Fagron Provides Earnings Guidance for the Fiscal Year 2024	04-11	CI
Fagron NV Proposes Dividend	02-15	CI
Fagron NV Provides Earnings Guidance for the Full Year 2024	02-15	CI
Fagron NV Reports Earnings Results for the Full Year Ended December 31, 2023	02-14	CI
Fagron NV completed the acquisiton of Parma Produkt Gyógyszergyártó Korlátolt Felelosségu Társaság.	01-22	CI
Fagron Seeks Acquisitions	23-10-12	CI
Fagron Nv Provides Earnings Guidance for 2023	23-10-12	CI
Fagron NV signed an agreement to acquire Parma Produkt Gyógyszergyártó Korlátolt Felelosségu Társaság.	23-10-11	CI
Fagron Completes Share Buyback Program	23-09-20	MT
Tranche Update on Fagron NV's Equity Buyback Plan announced on August 3, 2023.	23-09-19	CI
Fagron NV's Equity Buyback announced on August 3, 2023, has closed with 138,372 shares, representing 0.19% for ?2.26 million.	23-09-18	CI
Fagron NV Reports Earnings Results for the Half Year Ended June 30, 2023	23-08-03	CI
Fagron NV Provides Earnings Guidance for the Full Year 2023	23-08-03	CI
Fagron Seeks M&A	23-08-03	CI
Fagron NV announces an Equity Buyback for 138,372 shares.	23-08-03	CI
Fagron NV intends to launch an Equity Buyback.	23-08-03	CI
Fagron NV authorizes a Buyback Plan.	23-08-02	CI
Ex-dividend day for final dividend	23-05-14	FA
Fagron NV Approves Dividend for the Fiscal Year 2022, Payable on 17 May 2023	23-05-08	CI
Fagron NV acquired Wildlife Pharmaceuticals.	23-03-30	CI

No results for this search